Cai Weiliang
Partner @ Cowin Capital
Cai Weiliang is a partner at Cowin Capital. Prior to that, Cai served as the Head of Investment Banking and General Manager of Private Equity (Greater China) at OCBC Bank.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cai Weiliang invests in
Stages Cai Weiliang invests in
Countries Cai Weiliang invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Biotechnology 1 (100%)
- Manufacturing 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Innogen Pharmaceutical
|
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. | Venture - Series Unknown / Jul 19, 2022 |
Co-Investors
About Cowin Capital
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Cowin Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Cai Weiliang
Partner
|
|||
Ding Baoyu
Managing Director, Partner
|
|||
Dong Dongdong
Partner
|
|||
Dong Ming
Hangzhou Area Partner
|
|||
Huang Li
Founding Partner & CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cai Weiliang invest in?
Cai Weiliang invests primarily in Biopharma, Biotechnology and Manufacturing startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Cai Weiliang last invest?
The most recent investment recorded for Cai Weiliang closed in Jul 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
